Mitochondrial uptake of sestamibi distinguishes between normal, inflammatory breast changes, pre-cancers, and infiltrating breast cancer

Integrative Cancer Therapies

Volumn 1, Issue 3, 2002, Pages 229-237

  Fleming, Richard M ^a  

^a Camelot Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; BLOOD FLOW; BREAST; BREAST CANCER; BREAST DISEASE; BREAST TUMOR; CANCER SCINTISCANNING; CLINICAL ARTICLE; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; DRUG MEGADOSE; DRUG UPTAKE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; MAMMOGRAPHY; MASTITIS; METABOLISM; MITOCHONDRION; PRECANCER; PRIORITY JOURNAL; REFERENCE VALUE; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VASCULARIZATION; VASODILATATION;

EID: 0041321261     PISSN: 15347354     EISSN: None     Source Type: Journal    
DOI: 10.1177/153473540200100302     Document Type: Article

References (30)

1. Khalkhali I, Cutrone JA, Mena IG, et al. Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma. Radiology. 1995;196:421-426.
2. Khalkhali I, Villanueva-Meyer J, Edell SL, et al. Diagnostic accuracy of 99mTc-sestamibi breast imaging: multicenter trial results. J Nucl Med. 2000;41:1973-1979.
3. Carvalho PA, Chiu ML, Kronauge JF, et al. Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts. J Nucl Med. 1992;33:1516-1522.
4. Piwnica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium (I) in cultured chick myocardial cells: mitochondrial and plasma membrane potential dependence. Circulation. 1990;82:1826-1838.
5. Vanoli C, Antronaco R, Giovanella L, Ceriani L, Sessa F, Fugazzola C. 99mTc-MIBI characterization of breast microcalcifications: correlations with scintigraphic and histopathologic findings. Radiol Med. 1999;98:19-25.
6. Benard F, Lefebvre B, Beuvon F, Langlois MF, Bisson G. Rapid washout of technetium-99m-MIBI from a large parathyroid adenoma. J Nucl Med. 1995;36:241-243.
7. Arbab AS, Koizumi K, Hemmi A, et al. Tc-99m-MIBI scintigraphy for detecting parathyroid adenoma and hyperplasia. Ann Nucl Med. 1997;11:45-49.
8. Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium (I) in cultured mouse fibroblasts. J Nucl Med. 1990;31:1646-1653.
9. Backus M, Piwnica-Worms D, Hockett D, et al. Microprobe analysis of Tc-MIBI in heart cells: calculation of mitochondrial membrane potential. Am J Physiol. 1993;265:C178-C187.
10. Scopinaro F, De Vincentis G, Pani R, et al. 99Tcm-MIBI uptake in green plants. Nucl Med Commun. 1994;15:905-915.
11. Arbab AS, Koizumi K, Toyama K, Araki T. Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines. J Nucl Med. 1996;37:1551-1556.
12. Crane P, Laliberte R, Heminway S, Thoolen M, Orlandi C. Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention. Eur J Nucl Med. 1993;20:20-25.
13. Piwnica-Worms DP, Kronauge JF, LeFurgey A, et al. Mitochondrial localization and characterization of 99Tc-SESTAMIBI in heart cells by electron probe X-ray microanalysis and 99Tc-NMR spectroscopy. Magn Reson Imaging. 1994;12:641-652.
14. Pach J, Hubalewska-Hola A, Szybinski Z, Pach D. New possibilities in scintigraphy detection of carbon monoxide cardiotoxicity. Przegl Lek. 2001;58:182-184.
15. Piwnica-Worms D, Chiu ML, Kronauge JF. Detection of adriamycin-induced cardiotoxicity in cultured heart cells with technetium 99m-SESTAMIBI. Cancer Chemother Pharmacol. 1993;32:385-391.
16. Gunningham SP, Currie MJ, Han C, et al. VEGF-B expression in human primary breast cancers is associated with lymph node metastasis but not angiogenesis. J Pathol. 2001;193:325-332.
17. Pepper MS. Extracellular proteolysis and angiogenesis. Thromb Haemost. 2001;86:346-355.
18. Zhong S, Zhang Z, Li S. Significance of vascular endothelial growth factor expression in colorectal cancer. Zhonghua Nei Ke Za Zhi. 2001;40:514-516.
19. Fleming RM. Atherosclerosis: understanding the relationship between coronary artery disease and stenosis flow reserve. In: Chang JC, ed. Textbook of Angiology. New York, NY: Springer-Verlag; 1999:381-387.
20. Fleming RM. Nuclear cardiology: its role in the detection and management of coronary artery disease. In: Chang JC, ed. Textbook of Angiology. NewYork, NY Springer-Verlag; 1999:397-406.
21. Fleming RM, Boyd L, Forster M. Angina is caused by regional blood flow differences - proof of a physiologic (not anatomic) narrowing. Paper presented at: Joint Session of the European Society-American College of Cardiology, ACC 49th Annual Scientific Sessions; March 12, 2000; Anaheim, CA.
22. Fleming RM. Regional blood flow differences induced by high dose dipyridamole explain etiology of angina. Paper presented at: 3rd International College of Coronary Artery Disease From Prevention to Intervention; October 4, 2000; Lyon, France.
23. Fleming RM, Boyd LB, Kubovy C. Myocardial perfusion imaging using high dose dipyridamole defines angina: the difference between coronary artery disease (CAD) and coronary lumen disease (CLD). Paper presented at: 48th Annual Scientific Session of the Society of Nuclear Medicine; June 27, 2001; Toronto, Ontario, Canada.
24. Fleming RM. Coronary artery disease is more than just coronary lumen disease. Am J Cardiol. 2001;88:599-600.
25. Fleming RM, Rose CH, Feldmann KM. Comparing a high-dose dipyridamole SPECT imaging protocol with dobutamine and exercise stress testing protocols. Angiology. 1995;46:547-556.
26. Holdright DR, Lindsay DC, Clarke D, Fox K, Poole-Wilson PA, Collins P. Coronary flow reserve in patients with chest pain and normal coronary arteries. Br Heart J 1993;70:513-519.
27. Fleming RM, Dooley WC, Boyd LB, Kubovy C. Breast enhanced scintigraphy testing (BEST) - increased accuracy in detecting breast cancer accomplished by combining breast and cardiac imaging. Paper presented at: 48th Annual Scientific Session of the Society of Nuclear Medicine; June 26, 2001; Toronto, Ontario, Canada.
28. Folkman J, Merler E, Abernathy C, Williams G. Isolation of a tumor factor responsible for angiogenesis. J Exp Med. 1971;133:275-288.
29. Stewart RJ, Panigraphy D, Flynn E, Folkman J. Vascular endothelial growth factor expression and tumor angiogenesis are regulated by androgens in hormone responsive human prostate carcinoma: evidence for androgen dependent destabilization of vascular endothelial growth factor transcripts. J Urol. 2001;165:688-693.
30. Fleming RM. The pathogenesis of vascular disease. In: Chang JC, ed. Textbook of Angiology. New York, NY: Springer-Verlag; 1999:787-798.